BIVDA’s Chief Executive, Doris-Ann Williams MBE said “BIVDA saw the creation of the MedTech Directorate as a valuable and pragmatic step for our industry, in vitro diagnostics (IVDs) are a crucial part of the much wider MedTech sector".

"We welcome the Medical Technology Strategy which is comprehensive and covers all the aspects that our industry faces in delivering world class diagnostic testing to the NHS, including market access and regulation".

“We are committed to working closely with the MedTech Directorate to support the delivery of this Strategy".